132 related articles for article (PubMed ID: 37376985)
1. Overexpression of SMAD7 improves the function of EGFR-targeted human CAR-T cells against non-small-cell lung cancer.
Li G; Liao G; Xie J; Liu B; Li X; Qiu M
Respirology; 2023 Sep; 28(9):869-880. PubMed ID: 37376985
[TBL] [Abstract][Full Text] [Related]
2. SMAD7 expression in CAR-T cells improves persistence and safety for solid tumors.
Liang S; Zheng R; Zuo B; Li J; Wang Y; Han Y; Dong H; Zhao X; Zhang Y; Wang P; Meng R; Jia L; Yang A; Yan B
Cell Mol Immunol; 2024 Mar; 21(3):213-226. PubMed ID: 38177245
[TBL] [Abstract][Full Text] [Related]
3. Chimeric antigen receptor T cell targeting EGFRvIII for metastatic lung cancer therapy.
Zhang Z; Jiang J; Wu X; Zhang M; Luo D; Zhang R; Li S; He Y; Bian H; Chen Z
Front Med; 2019 Feb; 13(1):57-68. PubMed ID: 30721445
[TBL] [Abstract][Full Text] [Related]
4. Chemokine Receptors CCR6 and PD1 Blocking scFv E27 Enhances Anti-EGFR CAR-T Therapeutic Efficacy in a Preclinical Model of Human Non-Small Cell Lung Carcinoma.
Wang J; Wang Y; Pan H; Zhao L; Yang X; Liang Z; Shen X; Zhang J; Yang J; Zhu Y; Xun J; Liang Y; Lin Q; Liang H; Li M; Zhu H
Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982500
[TBL] [Abstract][Full Text] [Related]
5. Chimeric antigen receptor-modified T cells for the immunotherapy of patients with EGFR-expressing advanced relapsed/refractory non-small cell lung cancer.
Feng K; Guo Y; Dai H; Wang Y; Li X; Jia H; Han W
Sci China Life Sci; 2016 May; 59(5):468-79. PubMed ID: 26968708
[TBL] [Abstract][Full Text] [Related]
6. ILT4 inhibition prevents TAM- and dysfunctional T cell-mediated immunosuppression and enhances the efficacy of anti-PD-L1 therapy in NSCLC with EGFR activation.
Chen X; Gao A; Zhang F; Yang Z; Wang S; Fang Y; Li J; Wang J; Shi W; Wang L; Zheng Y; Sun Y
Theranostics; 2021; 11(7):3392-3416. PubMed ID: 33537094
[No Abstract] [Full Text] [Related]
7. Cellular immunotherapy for carcinoma using genetically modified EGFR-specific T lymphocytes.
Zhou X; Li J; Wang Z; Chen Z; Qiu J; Zhang Y; Wang W; Ma Y; Huang N; Cui K; Li J; Wei YQ
Neoplasia; 2013 May; 15(5):544-53. PubMed ID: 23633926
[TBL] [Abstract][Full Text] [Related]
8. Antitumor activity of EGFR-specific CAR T cells against non-small-cell lung cancer cells in vitro and in mice.
Li H; Huang Y; Jiang DQ; Cui LZ; He Z; Wang C; Zhang ZW; Zhu HL; Ding YM; Li LF; Li Q; Jin HJ; Qian QJ
Cell Death Dis; 2018 Feb; 9(2):177. PubMed ID: 29415996
[TBL] [Abstract][Full Text] [Related]
9. Phase I clinical trial of EGFR-specific CAR-T cells generated by the piggyBac transposon system in advanced relapsed/refractory non-small cell lung cancer patients.
Zhang Y; Zhang Z; Ding Y; Fang Y; Wang P; Chu W; Jin Z; Yang X; Wang J; Lou J; Qian Q
J Cancer Res Clin Oncol; 2021 Dec; 147(12):3725-3734. PubMed ID: 34032893
[TBL] [Abstract][Full Text] [Related]
10. Targeting Stat3 and Smad7 to restore TGF-β cytostatic regulation of tumor cells in vitro and in vivo.
Luwor RB; Baradaran B; Taylor LE; Iaria J; Nheu TV; Amiry N; Hovens CM; Wang B; Kaye AH; Zhu HJ
Oncogene; 2013 May; 32(19):2433-41. PubMed ID: 22751114
[TBL] [Abstract][Full Text] [Related]
11. Cbl-b mediates TGFβ sensitivity by downregulating inhibitory SMAD7 in primary T cells.
Gruber T; Hinterleitner R; Hermann-Kleiter N; Meisel M; Kleiter I; Wang CM; Viola A; Pfeifhofer-Obermair C; Baier G
J Mol Cell Biol; 2013 Dec; 5(6):358-68. PubMed ID: 23709694
[TBL] [Abstract][Full Text] [Related]
12. Functional characterization and development of novel human kinase insert domain receptor chimeric antigen receptor T-cells for immunotherapy of non-small cell lung cancer.
Zhong M; Chalbatani GM; Deng M; Li Q; Gharagouzloo E; Hamblin MR; Suarez ER; Hu L; Wang D
Eur J Pharm Sci; 2023 Jan; 180():106331. PubMed ID: 36384203
[TBL] [Abstract][Full Text] [Related]
13. Overexpression of smad7 blocks primary tumor growth and lung metastasis development in osteosarcoma.
Lamora A; Talbot J; Bougras G; Amiaud J; Leduc M; Chesneau J; Taurelle J; Stresing V; Le Deley MC; Heymann MF; Heymann D; Redini F; Verrecchia F
Clin Cancer Res; 2014 Oct; 20(19):5097-112. PubMed ID: 25107916
[TBL] [Abstract][Full Text] [Related]
14. c-Met specific CAR-T cells as a targeted therapy for non-small cell lung cancer cell A549.
Min J; Long C; Zhang L; Duan J; Fan H; Chu F; Li Z
Bioengineered; 2022 Apr; 13(4):9216-9232. PubMed ID: 35378051
[TBL] [Abstract][Full Text] [Related]
15. Development of FAP-Targeted Chimeric Antigen Receptor NK-92 Cells for Non-Small Cell Lung Cancer.
Fang Y; Wang YJ; Zhao HL; Huang X; Fang YN; Chen WY; Han RZ; Zhao A; Gao JM
Discov Med; 2023 Jun; 35(176):405-417. PubMed ID: 37272107
[TBL] [Abstract][Full Text] [Related]
16. Chimeric antigen receptor (CAR)-T-cell therapy in non-small-cell lung cancer (NSCLC): current status and future perspectives.
Qu J; Mei Q; Chen L; Zhou J
Cancer Immunol Immunother; 2021 Mar; 70(3):619-631. PubMed ID: 33025047
[TBL] [Abstract][Full Text] [Related]
17. The canonical TGF-β/Smad signalling pathway is involved in PD-L1-induced primary resistance to EGFR-TKIs in EGFR-mutant non-small-cell lung cancer.
Zhang Y; Zeng Y; Liu T; Du W; Zhu J; Liu Z; Huang JA
Respir Res; 2019 Jul; 20(1):164. PubMed ID: 31331328
[TBL] [Abstract][Full Text] [Related]
18. The TGFβ-SMAD3 pathway inhibits IL-1α induced interactions between human pancreatic stellate cells and pancreatic carcinoma cells and restricts cancer cell migration.
Tjomsland V; Sandnes D; Pomianowska E; Cizmovic ST; Aasrum M; Brusevold IJ; Christoffersen T; Gladhaug IP
J Exp Clin Cancer Res; 2016 Jul; 35(1):122. PubMed ID: 27473228
[TBL] [Abstract][Full Text] [Related]
19. SMAD7 antagonizes key TGFβ superfamily signaling in mouse granulosa cells in vitro.
Gao Y; Wen H; Wang C; Li Q
Reproduction; 2013 Jul; 146(1):1-11. PubMed ID: 23633623
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-182 targets SMAD7 to potentiate TGFβ-induced epithelial-mesenchymal transition and metastasis of cancer cells.
Yu J; Lei R; Zhuang X; Li X; Li G; Lev S; Segura MF; Zhang X; Hu G
Nat Commun; 2016 Dec; 7():13884. PubMed ID: 27996004
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
